The role of long non-coding RNAs in the pathogenesis of hereditary diseases

Abstract Background Thousands of long non-coding RNA (lncRNA) genes are annotated in the human genome. Recent studies showed the key role of lncRNAs in a variety of fundamental cellular processes. Dysregulation of lncRNAs can drive tumorigenesis and they are now considered to be a promising therapeu...

Full description

Saved in:
Bibliographic Details
Main Authors: Peter Sparber (Author), Alexandra Filatova (Author), Mira Khantemirova (Author), Mikhail Skoblov (Author)
Format: Book
Published: BMC, 2019-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_4b07bc0c97f644ab8a39efc1a5a86a68
042 |a dc 
100 1 0 |a Peter Sparber  |e author 
700 1 0 |a Alexandra Filatova  |e author 
700 1 0 |a Mira Khantemirova  |e author 
700 1 0 |a Mikhail Skoblov  |e author 
245 0 0 |a The role of long non-coding RNAs in the pathogenesis of hereditary diseases 
260 |b BMC,   |c 2019-03-01T00:00:00Z. 
500 |a 10.1186/s12920-019-0487-6 
500 |a 1755-8794 
520 |a Abstract Background Thousands of long non-coding RNA (lncRNA) genes are annotated in the human genome. Recent studies showed the key role of lncRNAs in a variety of fundamental cellular processes. Dysregulation of lncRNAs can drive tumorigenesis and they are now considered to be a promising therapeutic target in cancer. However, how lncRNAs contribute to the development of hereditary diseases in human is still mostly unknown. Results This review is focused on hereditary diseases in the pathogenesis of which long non-coding RNAs play an important role. Conclusions Fundamental research in the field of molecular genetics of lncRNA is necessary for a more complete understanding of their significance. Future research will help translate this knowledge into clinical practice which will not only lead to an increase in the diagnostic rate but also in the future can help with the development of etiotropic treatments for hereditary diseases. 
546 |a EN 
690 |a Long non-coding RNA 
690 |a lncRNA 
690 |a Hereditary disease 
690 |a Gene regulation 
690 |a Medical genetics 
690 |a Internal medicine 
690 |a RC31-1245 
690 |a Genetics 
690 |a QH426-470 
655 7 |a article  |2 local 
786 0 |n BMC Medical Genomics, Vol 12, Iss S2, Pp 63-78 (2019) 
787 0 |n http://link.springer.com/article/10.1186/s12920-019-0487-6 
787 0 |n https://doaj.org/toc/1755-8794 
856 4 1 |u https://doaj.org/article/4b07bc0c97f644ab8a39efc1a5a86a68  |z Connect to this object online.